Dr. Chiapperino is the Director of the Controlled Substance Staff (CSS), a group with expertise in the assessment of the abuse potential of drugs.  He has worked extensively on FDA policy and regulatory issues involving cannabis and related substances and, prior to CSS, was with CDER’s Division of Anesthesia, Analgesia, and Addiction Products gaining regulatory experience concerning opioids analgesics and drugs indicated for the treatment of substance use disorders.  He received his PhD in organic chemistry from the University…Read more